Micropulse Laser versus Eplerenone for Chronic Central Serous Chorioretinopathy: A 12-Month Comparison.

/ Publications / Micropulse Laser versus Eplerenone for Chronic Central Serous Chorioretinopathy: A 12-Month Comparison.

Micropulse Laser versus Eplerenone for Chronic Central Serous Chorioretinopathy: A 12-Month Comparison.

Authors: Viggiano, P., Boscia, G., Borrelli, E., Evangelista, F., Giancipoli, E., Mastropasqua, R., Quarta, A., Grassi, M. O., Aloia, R., Alessio, G., Toto, L., & Boscia, F.
Presented: January 1, 2024
Type: Publications

Conclusions: Both navigated subthreshold micropulse laser (NSML) and continuous oral eplerenone (EPL) improved retinal morphology and visual function in patients with cCSC. NSML achieved faster SRF resolution, while EPL resulted in more significant choroidal thickness reduction. These findings suggest distinct mechanisms of action: NSML primarily affects the retinal pigment epithelium, while EPL modulates choroidal vasculature. Treatment choice may depend on individual patient characteristics and treatment goals

Related publications and webinars

On-Demand Webinar: Navilas in der täglichen Praxis

Dr. Bernd Fassebender